Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)

NCT01564459 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy, Painful

Interventions

DRUG: MK-6096
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC